Product Images Pregabalin

This is a graph showing the percent of patients who have improved their pain levels from the baseline while taking Pregabalin 100mg three times a day versus those who took a placebo. The graph measures the percent improvement of pain from 100 to 290, with increments of 10, on the x-axis, and the number of patients on the y-axis.*

This is a chart showing the effectiveness of Pregabalin in reducing pain. It shows the dosages of Pregabalin administered to patients (ranging from 75 mg to 300 mg twice a day) and the corresponding percentage of patients whose pain levels improved. The chart also includes a placebo group with no Pregabalin.*

This text displays a chart showing the percent of patients who improved while taking either pregabalin at two different doses, or a placebo. It also shows a scale of percent improvement in pain from baseline.*

This is a chart that shows the percent of patients who improved after taking Pregabalin at different doses (100mg three times a day and 50mg three times a day) compared to those who took a placebo. The chart also displays the percent improvement in pain from baseline.*

The text provides data on the responder rates of patients in different studies for a particular medication. The data is presented in a table format and shows percentages of responder rates at different doses of the medication and for the placebo group. The highest response rate is seen with a dose of 600 mg/day, which is statistically significant compared to the placebo group.*

This text appears to be a chart or graph with percentages and drug/placebo names. It likely represents the estimated percentage of subjects who did not experience LTR (unknown acronym) while taking pregabalin compared to a placebo. The percentages range from 0% to 100%, with pregabalin potentially having a higher success rate than the placebo. The graph includes a timeline of days.*

The text indicates a graph displaying the percentage of subjects that improved after taking either Pregabalin or a Placebo medication, specifically from baseline to week 16. The data of those percentages is presented along a horizontal axis ranging from 230 to 270. It is not possible to determine what the percentage ranges represent or what the vertical axis displays.*

This text provides a formula for calculating the estimated glomerular filtration rate (eGFR) using the patient's age, weight, and serum creatinine levels. Specifically, it uses the Cockcroft-Gault equation (also known as Cler) to estimate renal function. The formula is adjusted for female patients by multiplying the result by 0.85.*

Each capsule contains 25 mg pregabalin. This medication guide is available for print at solcohealthcare.com/medguide/pregabalin-capsules.pdf. Store between 20°C to 25°C (68°F to 77°F), with limited excursions permitted. Dispense in tight containers. This medication is distributed by Solco Healthcare in the US but manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd in China. This is a prescription-only medication.*

Each capsule contains 50 mg of pregabain. The dosage and usage information can be found in the accompanying prescribing information. The medication should be stored in tight containers, at temperatures between 20°C to 25°C (68°F to 77°F), with some excursions allowed between 15°C to 30°C (59°F to 86°F). The medication guide can be printed from the website mentioned. Pregabalin Capsules are manufactured by Zhejiang Huahai Pharmaceutical Co. Ltd and distributed by Solco Healthcare US, LLG, based in Somerset, NJ. The rest of the text is not legible.*

Each capsule of this medication contains 75mg of pregabalin. It is important to store this medication at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted for 15°C to 30°C (59°F to 86°F). This medication should be dispensed in tight containers (USP). Detailed prescribing information is provided with this medication. A medication guide can be printed from the website mentioned on the box. This medication is distributed by Solco Healthcare US, LLC and manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd, Xungiao, Linhai, Zhejiang, China.*

This is a medication description for Pregabalin capsules. Each capsule contains 100mg of the medication. The recommended dosage and further information can be found in the accompanying prescribing information. The medication should be stored within a temperature range of 20°C to 25°C (68°F to 77°F) but can be excursed to a maximum of 15°C to 30°C (59°F to 86°F). Dispense medication in a tight container. The Pregabalin Capsules medication guide can be found by accessing the website provided. Manufactured by Zhejiang Huahai Pharmaceutical Co. in China, the medication is distributed by Soko Healthcare US, LLC in Somerset, NJ. The rest of the content is unclear and not available.*

Each capsule contains 150mg of pregabalin. It is important to store the medication at a temperature between 20°C to 25°C (68°F to 77°F); however temperature excursions are permitted. Dispense in tight containers (USP). The prescribing information should be consulted for dosage and use information. The medication guide is available on solcohealthcare.com. The medication is manufactured in China by Zhejiang Huahai Pharmaceutical Co., Ltd and distributed by Solco Healtheare US, LLC in the USA. This product contains 90 capsules.*

Each capsule has a 200 mg dose of pregabalin. Store the capsules in tight containers at a temperature between 20°C to 25°C. Dispense as per the accompanying information available at ww solcohealthcare.com/medguidelpregabalin-capsules.pdf. The medication guide must be provided separately to each patient. The manufacturer is Zhejiang Huahai Pharmaceutical o, Ltd, located in Xungiao, Linhai, Zhejiang 317024, China. Solco Healthcare US, LLC distributes the capsules, and the product does not require coating.*

Each capsule contains 225 mg of Pregabalin which is to be stored in tight containers at a temperature range of 20°C to 25°C with excursions permitted to 16°C to 30°C. Dispensing of this medicine requires accompanying prescribing information. The medication guide for Pregabalin capsules can be printed from solcohealthcare.comimedguidelpregabalin-capsules pdf. Ronly [N M CLEL L] NDC 43547-512-09 is provided and manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd at Xungiao, Linhai, Zhejiang 317024, China, and distributed by Solco HealthCare US, LLG located at Somerset, NJ 08873, USA. However, the failed to capture a major part of the description as it only provides dosage and storage information.*

This is a medication called Pregabalin contained in capsules of 300mg. The dosage instructions are not provided and the users should follow the prescribing information. The product should be kept at temperatures between 20°C to 25°C (68°F to 77°F). The product is manufactured in China by Zhejiang Huahai Pharmaceutical Co., Ltd., and distributed in the US by Solco Healthcare US, LLC. No other information is available.*

The text shows the responder rate percentage for different dosages of a certain treatment and a placebo. The treatment doses are specified as 2.5 mglkg/day and 10 mg/kg/day. The responder rates for these dosages are 29.1% and 22.6%, respectively. The responder rate for the placebo is 40.6%. The numbers 93, 103, and 96 are not interpretable without additional information.*